Skip to main content

Year: 2022

SANUWAVE’s Energy First Technology to be Featured in 3 Clinical Posters at Upcoming 2022 Fall Symposium on Advanced Wound Care (SAWC)

EDEN PRAIRIE, MN, Oct. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, is excited to announce that three abstracts highlighting the role of the company’s dermaPACE system in clinical cases were accepted to the Poster Presentation Hall at the upcoming 2022 Fall Symposium on Advanced Wound Care (SAWC)  hosted by HMP Global. The conference is one of wound care’s most esteemed events and will take place at Caesars Palace, Las Vegas, Nevada from October 13-16, 2022. The following clinical cases, which examine the use of dermaPACE in patients with chronic, complex, and challenging wounds, will be presented. 1.)   The Use of Non-Invasive Extracorporeal Shockwave Therapy (ESWT) Pulsed Acoustic Cellular Expression (PACE) System In Complex Wounds...

Continue reading

Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer

CAMBRIDGE, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that Eyal C. Attar, M.D., has joined Vor Bio as Chief Medical Officer (CMO). Dr. Attar brings more than 20 years of demonstrated clinical experience to the position, with previous roles as a clinician, bench researcher and clinical developer of treatments for hematologic malignancies. “This is a time of tremendous momentum for Vor Bio with initial data expected later this year for our ongoing clinical trial of VOR33, and as we work towards our IND submission for VCAR33ALLO in the first half of next year,” said Dr. Robert Ang, Vor Bio’s President and Chief Executive Officer. “Vor will greatly benefit from Eyal’s breadth and depth of clinical development experience in acute myeloid leukemia...

Continue reading

Pasithea Therapeutics Acquires AlloMek Therapeutics

— Expands CNS Product Portfolio with Addition of CIP-137401, a Macrocyclic, Next-Generation MEK Inhibitor — Plans to File IND Application with the FDA to Enter the Clinic in 2H 2023 — Plans to Initiate a Phase 1 Clinical Trial in the U.S. for Neurofibromatosis Type 1 (NF1) — Management to Host an Investor Webcast Today at 9 a.m. ET MIAMI BEACH, Fla., Oct. 12, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders, today announced that it acquired AlloMek Therapeutics, LLC (“AlloMek”), a privately-held biotechnology company. AlloMek’s lead therapeutic candidate, CIP-137401, is a potential best-in-class macrocyclic mitogen-activated...

Continue reading

Asia Broadband Completes Third Quarter Production and Continues Facilities Expansion at the Tequila Gold Mine Project in Mexico

LAS VEGAS, Oct. 12, 2022 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has recently completed a full quarter of production at its Tequila Gold Mine Project in the Tequila region of Mexico. The production revenue for the 3rd quarter ending September 30, 2022, is in the process of being finalized and will be published in the coming weeks. The Company is expecting the 3rd quarter production revenue to exceed the level recorded in the 2nd quarter, as the production facilities expansion is on going. The Tequila production facilities upgrade program continues to progress towards an additional 50 tons per day (tpd) production capacity. After the facilities retrofit is complete, the mill capacity will be 100 tpd and double the current processing limit of 50 tpd. Due...

Continue reading

FirstService to Announce Third Quarter Results on October 26, 2022

TORONTO, Oct. 12, 2022 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that it will release its financial results for the third quarter ended September 30, 2022 by press release on Wednesday, October 26, 2022 at approximately 7:30 am ET. The conference call to review these financial results will take place at 11:00 am ET on Wednesday, October 26, 2022, and will be hosted by D. Scott Patterson, CEO, and Jeremy Rakusin, CFO. This call is being webcast live at the Company’s website at www.firstservice.com. Participants may register for the call here https://register.vevent.com/register/BIfb2219ba36ad4fa3b8d54fa47742fdd4 to receive the dial-in number and their unique PIN. To join the webcast in listen only mode, use this link: https://edge.media-server.com/mmc/p/no64uxht . It is recommended...

Continue reading

Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium

MONTREAL, Oct. 12, 2022 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company will present data from tissue microarrays showing high expression of SORT1, the target for Theratechnologies’ oncology platform, in several cancer types. The data will be presented in a poster session at the 34th joint symposium of the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI), and the American Association for Cancer Research (AACR), to be held October 26-28, 2022, in Barcelona, Spain. “We look forward to presenting data from tissue microarrays at the EORTC-NCI-AACR symposium, as the findings reinforce SORT1...

Continue reading

Amesite Named One of Michigan’s 2022 Best and Brightest in Wellness and Metro Detroit’s 2022 Best and Brightest Companies to Work For by the NABR

DETROIT, Oct. 12, 2022 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced today it had received two awards from the National Association for Business Resources: Michigan’s 2022 Best and Brightest in Wellness and Metro Detroit’s 2022 Best and Brightest Companies to Work For. “Our leaders have recruited and promoted talented, dedicated colleagues who are committed to our strong culture,” said Amesite founder and CEO Dr. Ann Marie Sastry. “As we have secured new, larger contracts and rolled out enterprise-scale technology solutions, our team has brought our core values to our work with Customers to enable them to be successful and scale learning.” “We are honored to appear on both of these prestigious...

Continue reading

Repligen to Report Third Quarter 2022 Financial Results

Webcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2022 financial results on Tuesday, November 1, 2022. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. EDT to discuss business updates and financial results for the three- and nine- month reporting periods ended September 30, 2022. The conference call will be accessible by dialing toll-free (844) 274-3999 for domestic callers and (412) 317-5607 for international callers. No passcode is required for the live call. In addition, a webcast will be accessible via the Investor Relations section of the Company’s website. Both the conference call and webcast...

Continue reading

E-Home Household Services Holdings Limited Signs Multiple Household Cleaning and Maintenance Service Contracts

FUZHOU, China, Oct. 12, 2022 (GLOBE NEWSWIRE) — E-Home Household Service Holdings Limited (Nasdaq: EJH) (the “Company” or “E-Home”), a provider of integrated household services in China, today announced the Company has signed multiple household cleaning service contracts to provide both daily hygiene maintenance and domestic garbage sorting and dumping services for properties under management of long-term clients in Fujian province, China. Pursuant to the five contracts signed, E-Home will provide cleaning services in public areas including carparks, green belts, passages and public facilities, public restrooms, among others. E-Home’s crew will also be in charge of garbage collection, transfer and dumping services for the residencies managed by Zhengrong Property Service Co. Ltd., Fuzhou Company and Fujian Fusheng Property Management...

Continue reading

MariMed Announces Third Quarter 2022 Earnings Date

NORWOOD, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) — MariMed, Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its third quarter 2022 financial results on November 7, 2022 after the market closes. Management will host a conference call on November 8, 2022 at 8:00 a.m. EST to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q322 Earnings Webcast. To listen to the live call, please visit the website at least 15 minutes prior to the call to register, download and install any necessary audio software. A playback of the call will be archived on MariMed’s website for approximately 30 days. About MariMedMariMed Inc., a multi-state cannabis operator,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.